Ragosa Mark sold KNSA
November 12, 2025 · Form 4 insider transaction
Ragosa Mark sold 19,900 shares of Kiniksa Pharmaceuticals International, plc at $40.94 per share, a transaction worth $814.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
19,900
Price
$40.94
Total value
$814.7K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after31,086
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $40.93 and $41.035. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.